BRPI1013012A2 - identificação de pequenas moléculas reconhecidas por anticorpos em indivíduos com doenças neurodegenerativas - Google Patents
identificação de pequenas moléculas reconhecidas por anticorpos em indivíduos com doenças neurodegenerativasInfo
- Publication number
- BRPI1013012A2 BRPI1013012A2 BRPI1013012A BRPI1013012A BRPI1013012A2 BR PI1013012 A2 BRPI1013012 A2 BR PI1013012A2 BR PI1013012 A BRPI1013012 A BR PI1013012A BR PI1013012 A BRPI1013012 A BR PI1013012A BR PI1013012 A2 BRPI1013012 A2 BR PI1013012A2
- Authority
- BR
- Brazil
- Prior art keywords
- individuals
- identification
- neurodegenerative diseases
- small antibody
- molecules
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18326009P | 2009-06-02 | 2009-06-02 | |
US31865510P | 2010-03-29 | 2010-03-29 | |
PCT/US2010/036827 WO2010141421A1 (en) | 2009-06-02 | 2010-06-01 | Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1013012A2 true BRPI1013012A2 (pt) | 2016-10-18 |
Family
ID=42269525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1013012A BRPI1013012A2 (pt) | 2009-06-02 | 2010-06-01 | identificação de pequenas moléculas reconhecidas por anticorpos em indivíduos com doenças neurodegenerativas |
Country Status (16)
Country | Link |
---|---|
US (1) | US9551721B2 (pt) |
EP (1) | EP2438444A1 (pt) |
JP (1) | JP5828837B2 (pt) |
KR (1) | KR20120122869A (pt) |
CN (1) | CN102439451B (pt) |
AU (1) | AU2010256880B2 (pt) |
BR (1) | BRPI1013012A2 (pt) |
CA (1) | CA2764153C (pt) |
CL (1) | CL2011002973A1 (pt) |
CO (1) | CO6450654A2 (pt) |
HK (1) | HK1169709A1 (pt) |
IL (1) | IL216689A (pt) |
MX (1) | MX2011012933A (pt) |
RU (1) | RU2566064C2 (pt) |
TW (1) | TWI569014B (pt) |
WO (1) | WO2010141421A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014504594A (ja) | 2011-01-10 | 2014-02-24 | オプコ ファーマシューティカルズ、エルエルシー | 自己免疫疾患における抗原代用物 |
MX2013011000A (es) * | 2011-03-24 | 2014-03-27 | Opko Pharmaceuticals Llc | Descubrimiento de biomarcador en fluido biologico complejo usando genotecas basadas en microesferao particula y kits de diagnostico y terapeuticos. |
WO2012154484A1 (en) * | 2011-05-06 | 2012-11-15 | Elwha Llc | Compositions and methods for antibody and ligand identification |
US11360098B2 (en) * | 2015-09-28 | 2022-06-14 | Quest Diagnostics Investments Llc | Amyloid beta detection by mass spectrometry |
AU2016338410B2 (en) | 2015-10-14 | 2021-07-15 | X-Therma, Inc. | Compositions and methods for reducing ice crystal formation |
WO2017156324A1 (en) | 2016-03-09 | 2017-09-14 | Mike-Ann, Llc | Peptoid affinity ligands |
WO2017165438A1 (en) | 2016-03-25 | 2017-09-28 | Muralidhar Reddy Moola | Combinatorial synthesis and biomarker development |
CN106866794B (zh) * | 2017-02-15 | 2020-09-08 | 国家纳米科学中心 | 一种类肽及其制备方法和应用 |
CN108484905A (zh) * | 2018-04-16 | 2018-09-04 | 青岛科技大学 | 一种侧链含羧基具有ucst行为的聚类肽及其制备方法 |
WO2019211878A1 (en) * | 2018-05-04 | 2019-11-07 | Council Of Scientific And Industrial Research, An Indian Registered Body Incorporated Under The Registration Of Societies Act (Act Xxi Of 1860) | Peptoid of formula i, pharmaceutical compositions and method for preparation thereof |
CN108586579B (zh) * | 2018-05-11 | 2021-11-30 | 京东方科技集团股份有限公司 | 一种类肽及其衍生物、盐、制备方法和用途 |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
US4789628A (en) | 1986-06-16 | 1988-12-06 | Vxr, Inc. | Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices |
CA1304682C (en) | 1986-11-19 | 1992-07-07 | Nobuo Monji | Membrane affinity concentration immunoassay |
US5149626A (en) | 1987-05-14 | 1992-09-22 | Mclean Hospital Corporation | Multiple antigen immunoassay |
EP0317804B1 (en) | 1987-11-24 | 1995-10-04 | Abbott Laboratories | HIV peptides and methods for detection of HIV |
DE4040669A1 (de) | 1990-12-19 | 1992-06-25 | Behringwerke Ag | Verwendung von peptidpaaren mit extrem hoher spezifischer affinitaet zueinander im bereich der in vitro diagnostik |
DK51092D0 (da) | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
CA2115333A1 (en) | 1993-02-16 | 1994-08-17 | Shigeo Hozumi | Polyfunctional vinyl ether compounds and photoresist resin composition containing the same |
US5705614A (en) | 1993-04-09 | 1998-01-06 | Chiron Corporation | Methods of producing antigen forks |
JP3639594B2 (ja) | 1993-05-28 | 2005-04-20 | ベイラー カレッジ オブ メディシン | 分析対象物の脱着およびイオン化のための方法および装置 |
ZA95605B (en) | 1994-04-28 | 1995-12-20 | Qualcomm Inc | Method and apparatus for automatic gain control and dc offset cancellation in quadrature receiver |
AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
ES2303338T3 (es) | 1995-06-07 | 2008-08-01 | Glaxo Group Limited | Peptidos y compuestos que se unen a un receptor de trombopoyetina. |
JPH1025299A (ja) | 1996-07-12 | 1998-01-27 | Nec Corp | 整列ペプチド、及びそれを用いたタンパク質の結合・相互作用部位検出方法 |
US20020022227A1 (en) | 1996-10-17 | 2002-02-21 | Short Jay M. | Morphatides: novel shape and structure libraries |
US20020006620A1 (en) | 1996-10-17 | 2002-01-17 | Invitrogen Corporation | Morphatides: novel shape and structure libraries |
WO1998027209A1 (en) | 1996-12-18 | 1998-06-25 | Emory University | Polycationic oligomers |
WO1998046796A1 (en) | 1997-04-11 | 1998-10-22 | The Regents Of The University Of California | A method of screening nucleotide sequences to identify disruptors or effectors of biological processes or pathways |
NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
US6344330B1 (en) | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
WO1999051773A1 (en) | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
US6406632B1 (en) | 1998-04-03 | 2002-06-18 | Symyx Technologies, Inc. | Rapid characterization of polymers |
WO1999067640A1 (en) | 1998-06-22 | 1999-12-29 | The Regents Of The University Of California | Triggered optical biosensor |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6780582B1 (en) | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
US6197599B1 (en) | 1998-07-30 | 2001-03-06 | Guorong Chin | Method to detect proteins |
US6306643B1 (en) | 1998-08-24 | 2001-10-23 | Affymetrix, Inc. | Methods of using an array of pooled probes in genetic analysis |
AU774367C (en) * | 1998-11-06 | 2005-04-21 | University Of Zurich | Nucleotide and protein sequences of nogo genes and methods based thereon |
AU4025300A (en) | 1999-03-24 | 2000-10-09 | Packard Bioscience Company | Continuous porous matrix arrays |
US6465183B2 (en) | 1999-07-01 | 2002-10-15 | Agilent Technologies, Inc. | Multidentate arrays |
WO2001027624A2 (en) | 1999-10-08 | 2001-04-19 | Superarray, Inc. | Compositions and methods for detecting protein modification and enzymatic activity |
WO2001033230A2 (en) | 1999-11-02 | 2001-05-10 | Chiron Corporation | Biological sample component purification and differential display |
AU2001233276A1 (en) | 2000-02-03 | 2001-08-14 | Immunomatrix Inc. | Method and apparatus for signal transduction pathway profiling |
EP1267904A4 (en) | 2000-02-16 | 2006-02-08 | Univ Northwestern | POLYPEPTIDE PULMONAL TENSIDES |
JP4860085B2 (ja) | 2000-03-16 | 2012-01-25 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 表面結合リガンドから溶出された分析物を捕捉するための方法 |
CA2723664A1 (en) | 2000-03-22 | 2001-09-27 | Solulink, Incorporated | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
AU2001259512B2 (en) | 2000-05-04 | 2007-03-01 | Yale University | High density protein arrays for screening of protein activity |
AU2001261533A1 (en) | 2000-05-12 | 2001-11-26 | Dumas, David P | Compositions and methods for epitope mapping |
US20020098493A1 (en) | 2000-05-25 | 2002-07-25 | Asher Nathan | Drug-amino acids chimeric molecules |
US7153682B2 (en) | 2000-06-05 | 2006-12-26 | Chiron Corporation | Microarrays on mirrored substrates for performing proteomic analyses |
US7148058B2 (en) | 2000-06-05 | 2006-12-12 | Chiron Corporation | Protein microarrays on mirrored surfaces for performing proteomic analyses |
ES2281424T3 (es) | 2000-06-05 | 2007-10-01 | Novartis Vaccines And Diagnostics, Inc. | Micromatrices para llevar a cabo analisis proteomicos. |
US20020013334A1 (en) * | 2000-06-15 | 2002-01-31 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
DE60130211T2 (de) | 2000-06-23 | 2008-05-29 | Domantis Ltd., Brentford | Matrix-screening-verfahren |
DK1309861T3 (da) | 2000-08-15 | 2006-10-23 | Discerna Ltd | Funktionelle protein-arrays |
AU2001285252A1 (en) | 2000-08-25 | 2002-03-13 | Gendaq, Ltd. | Analysis of binding interactions |
GB0022978D0 (en) | 2000-09-19 | 2000-11-01 | Oxford Glycosciences Uk Ltd | Detection of peptides |
EP1197755A1 (en) | 2000-10-11 | 2002-04-17 | Pepscan Systems B.V. | Identification of protein binding sites |
CA2432639A1 (en) | 2000-11-16 | 2002-05-23 | Cemines, Llc | Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease |
US20020137104A1 (en) | 2000-11-27 | 2002-09-26 | Antonio Cosma | High throughput determination of antigen expression |
AU2002230788A1 (en) | 2000-12-11 | 2002-06-24 | Hk Pharmaceuticals, Inc. | Multiplexed protein expression and activity assay |
CA2434139C (en) | 2001-01-23 | 2014-05-27 | President And Fellows Of Harvard College | Nucleic-acid programmable protein arrays |
CA2435608A1 (en) | 2001-02-05 | 2002-08-15 | Graffinity Pharmaceutical Design Gmbh | Low affinity screening method |
US20020137106A1 (en) | 2001-03-09 | 2002-09-26 | Ciphergen Biosystems, Inc. | Detection of biological pathway components |
WO2002073209A2 (de) | 2001-03-10 | 2002-09-19 | Affina Immuntechnik Gmbh | Verfahren zur identifikation von immunreaktiven epitopen auf proteinen |
WO2002084249A2 (en) | 2001-04-10 | 2002-10-24 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic and diagnostic uses of antibody specificity profiles |
WO2002084252A2 (en) | 2001-04-17 | 2002-10-24 | Xenoport, Inc. | Epitope-captured antibody display |
JP2004536290A (ja) | 2001-04-19 | 2004-12-02 | ゲゼルシャフト フュア バイオテクノロギッシェ フォーシュンク エム ベー ハー(ゲー ベー エフ) | 安定した、再生可能な抗体アレイの作製方法 |
US6989276B2 (en) | 2001-05-10 | 2006-01-24 | Battelle Energy Alliance, Llc | Rapid classification of biological components |
WO2003019192A1 (en) | 2001-08-27 | 2003-03-06 | The Trustees Of Boston University | Apparatus, composition and method for proteome profiling |
AU2002367732A1 (en) | 2001-10-31 | 2003-09-09 | Children's Hospital Medical Center | Method for diagnosis and treatment of rheumatoid arthritis |
EP1319954A1 (en) | 2001-12-12 | 2003-06-18 | Centre National de Genotypage | Methods for protein analysis using protein capture arrays |
US7504364B2 (en) | 2002-03-01 | 2009-03-17 | Receptors Llc | Methods of making arrays and artificial receptors |
EP1565744A4 (en) | 2002-03-07 | 2007-06-20 | Zephyr Proteomix Ltd | MICROARRAY'S CELLULOSE BINDING CHIMERIC PROTEINS AND METHOD OF USE THEREOF |
US7736909B2 (en) | 2003-01-09 | 2010-06-15 | Board Of Regents, The University Of Texas System | Methods and compositions comprising capture agents |
WO2005007677A2 (en) | 2003-07-10 | 2005-01-27 | The Institute For Systems Biology | Affinity capture of peptides by microarray and related methods |
GB2404734A (en) | 2003-08-05 | 2005-02-09 | Secr Defence | A method of screening a sample for abnormally glycosylated and/or expressed proteins |
WO2006028930A2 (en) | 2004-09-03 | 2006-03-16 | Receptors Llc | Combinatorial artificial receptors including tether building blocks on scaffolds |
EP1688137A1 (en) * | 2005-01-28 | 2006-08-09 | Schwarz Pharma Ag | SPM 927 for add-on therapy of schizophrenia |
WO2006124644A2 (en) * | 2005-05-12 | 2006-11-23 | Board Of Regents, The University Of Texas System | Protein and antibody profiling using small molecule microarrays |
CA2621767A1 (en) | 2005-09-09 | 2007-03-15 | Novartis Ag | Prion-specific peptoid reagents |
CA2666507A1 (en) | 2006-10-16 | 2008-04-24 | The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona A Cting For And On Behalf Of Arizona State University | Synthetic antibodies |
KR20120034683A (ko) | 2009-05-29 | 2012-04-12 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 자가면역 t-세포의 분리 및 처리를 위한 펩토이드 리간드 |
-
2010
- 2010-06-01 KR KR1020117031453A patent/KR20120122869A/ko not_active Application Discontinuation
- 2010-06-01 AU AU2010256880A patent/AU2010256880B2/en not_active Ceased
- 2010-06-01 CN CN201080023987.9A patent/CN102439451B/zh not_active Expired - Fee Related
- 2010-06-01 EP EP10721259A patent/EP2438444A1/en not_active Withdrawn
- 2010-06-01 CA CA2764153A patent/CA2764153C/en active Active
- 2010-06-01 JP JP2012514031A patent/JP5828837B2/ja not_active Expired - Fee Related
- 2010-06-01 MX MX2011012933A patent/MX2011012933A/es active IP Right Grant
- 2010-06-01 BR BRPI1013012A patent/BRPI1013012A2/pt not_active Application Discontinuation
- 2010-06-01 US US12/791,389 patent/US9551721B2/en active Active
- 2010-06-01 RU RU2011154154/15A patent/RU2566064C2/ru active IP Right Revival
- 2010-06-01 WO PCT/US2010/036827 patent/WO2010141421A1/en active Application Filing
- 2010-06-02 TW TW099117859A patent/TWI569014B/zh not_active IP Right Cessation
-
2011
- 2011-10-21 CO CO11141472A patent/CO6450654A2/es not_active Application Discontinuation
- 2011-11-24 CL CL2011002973A patent/CL2011002973A1/es unknown
- 2011-11-30 IL IL216689A patent/IL216689A/en not_active IP Right Cessation
-
2012
- 2012-10-18 HK HK12110345.7A patent/HK1169709A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20120122869A (ko) | 2012-11-07 |
CN102439451B (zh) | 2014-12-03 |
MX2011012933A (es) | 2012-03-07 |
CN102439451A (zh) | 2012-05-02 |
US20100303805A1 (en) | 2010-12-02 |
RU2566064C2 (ru) | 2015-10-20 |
TWI569014B (zh) | 2017-02-01 |
EP2438444A1 (en) | 2012-04-11 |
AU2010256880B2 (en) | 2015-01-22 |
CA2764153C (en) | 2021-07-27 |
JP2012529053A (ja) | 2012-11-15 |
HK1169709A1 (en) | 2013-02-01 |
US9551721B2 (en) | 2017-01-24 |
AU2010256880A1 (en) | 2011-11-03 |
CA2764153A1 (en) | 2010-12-09 |
IL216689A (en) | 2016-09-29 |
CO6450654A2 (es) | 2012-05-31 |
WO2010141421A1 (en) | 2010-12-09 |
CL2011002973A1 (es) | 2012-03-23 |
JP5828837B2 (ja) | 2015-12-09 |
IL216689A0 (en) | 2012-02-29 |
TW201109662A (en) | 2011-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1013012A2 (pt) | identificação de pequenas moléculas reconhecidas por anticorpos em indivíduos com doenças neurodegenerativas | |
BRPI1015379A2 (pt) | sistemas de cálculo biométrico e métodos | |
BRPI0914623A2 (pt) | identificação de consulta e associação | |
BR112012003867A2 (pt) | sistema de visão e exibição integrado | |
BR112012016918A2 (pt) | detecção do risco de pré-eclâmpsia | |
BR112012009704A2 (pt) | dispositivo de iluminação com funcionalidade de despertar e / ou dormir | |
BRPI1007939A2 (pt) | "identificação de aspectos de consulta" | |
BRPI1007641A2 (pt) | estrutura compósita sobremoldada e processo | |
BRPI0915487A2 (pt) | hemaglutina de nfluenza e variantes de neuraminidase | |
BRPI0910116A2 (pt) | desvio transparente e mecanismos associados | |
BR112012000025A2 (pt) | polipeptídos e processo de tratamento. | |
BRPI1012854A2 (pt) | processo de curtimento e composição de curtimento | |
BRPI1008795A2 (pt) | processos de alquilação e de hidroconversão | |
DK2260994T3 (da) | Formsystem samt anvendelse deraf | |
BRPI0814685A2 (pt) | variantes com splicing de cd44 em doenças neurodegenerativas | |
BRPI0914151A2 (pt) | distribuidor de medicamento e método | |
BRPI0915036A2 (pt) | processo de produção de caspofungina e seus intermediários | |
FI20090161A0 (fi) | Uusi solu ja siihen pohjautuvia terapeuttisia ja diagnostisia menetelmiä | |
BR112012004270A2 (pt) | veículo portuário modular e evolutivo | |
DK2443304T3 (da) | Person- eller laststighjælp | |
BRPI0923635A2 (pt) | pesquisa audiovisual e interface de navegação | |
BRPI0917940A2 (pt) | cartão de identificação | |
BRPI1008392A2 (pt) | Populações de monócito isoladas e aplicações terapêuticas relacionadas | |
BRPI1013785A2 (pt) | sensor óptico para identificar e/ou autenticar objetos | |
BRPI0917541A2 (pt) | utilização de soforicosida na fabricação de medicamentos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001 |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |